Nothing Special   »   [go: up one dir, main page]

WO2009060083A3 - Use of an n-acylated sarcosinate as an agent against microbial adhesion - Google Patents

Use of an n-acylated sarcosinate as an agent against microbial adhesion Download PDF

Info

Publication number
WO2009060083A3
WO2009060083A3 PCT/EP2008/065173 EP2008065173W WO2009060083A3 WO 2009060083 A3 WO2009060083 A3 WO 2009060083A3 EP 2008065173 W EP2008065173 W EP 2008065173W WO 2009060083 A3 WO2009060083 A3 WO 2009060083A3
Authority
WO
WIPO (PCT)
Prior art keywords
sarcosinate
preventing
formula
skin
agent against
Prior art date
Application number
PCT/EP2008/065173
Other languages
French (fr)
Other versions
WO2009060083A2 (en
Inventor
Géraldine Lerebour
Original Assignee
L'oreal
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by L'oreal filed Critical L'oreal
Publication of WO2009060083A2 publication Critical patent/WO2009060083A2/en
Publication of WO2009060083A3 publication Critical patent/WO2009060083A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q15/00—Anti-perspirants or body deodorants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/005—Antimicrobial preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/005—Preparations for sensitive skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/007—Preparations for dry skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

The present invention relates to the cosmetic use of an N-acylated sarcosinate of formula (I) as an agent for preventing or reducing the adhesion of microorganisms to the surface of the skin and/or of the mucosae, in particular of Staphylococcus aureus. It also relates to a cosmetic process aimed at preventing and/or reducing the adhesion of microorganisms to skin exhibiting an impaired barrier function, comprising the application, to the skin of individuals exhibiting an impaired barrier function, of a composition comprising at least one sarcosinate of formula (I). It also relates to the use of at least one sarcosinate of formula (I), for the preparation of a pharmaceutical composition for use in preventing and/or treating atopic dermatitis.
PCT/EP2008/065173 2007-11-08 2008-11-07 Use of an n-acylated sarcosinate as an agent against microbial adhesion WO2009060083A2 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
FR0758875A FR2923383B1 (en) 2007-11-08 2007-11-08 USE OF AN N-ACYLATED SARCOSINATE AS A MICROBIAL ANTI-ADHESION AGENT.
FR0758875 2007-11-08
US98742507P 2007-11-13 2007-11-13
US60/987,425 2007-11-13

Publications (2)

Publication Number Publication Date
WO2009060083A2 WO2009060083A2 (en) 2009-05-14
WO2009060083A3 true WO2009060083A3 (en) 2010-12-23

Family

ID=39591644

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2008/065173 WO2009060083A2 (en) 2007-11-08 2008-11-07 Use of an n-acylated sarcosinate as an agent against microbial adhesion

Country Status (2)

Country Link
FR (1) FR2923383B1 (en)
WO (1) WO2009060083A2 (en)

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2901399A (en) * 1955-05-20 1959-08-25 Bristol Myers Co Therapeutic preparations for topical application to the skin
GB1436614A (en) * 1972-07-17 1976-05-19 Thomae Gmbh Dr K Dermatological compositions
FR2450107A1 (en) * 1976-06-24 1980-09-26 Rorer Inc William H NEW COSMETIC AND PHARMACEUTICAL DETERGENT COMPOSITIONS BASED ON SARCOSINE
WO1999004757A1 (en) * 1997-07-24 1999-02-04 Societe D'exploitation De Produits Pour Les Industries Chimiques Seppic Use of a lipoaminoacid in a cosmetic formulation
WO2002013776A2 (en) * 2000-08-11 2002-02-21 The Procter & Gamble Company Method of providing improved deodorant application to the underarm
US20050037039A1 (en) * 2003-08-12 2005-02-17 Yarbrough William M. Composition for treatment of tinea pedis and method of use
WO2005018629A1 (en) * 2003-08-12 2005-03-03 Yarbrough William M Treatment for acne vulgaris and method of use

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2901399A (en) * 1955-05-20 1959-08-25 Bristol Myers Co Therapeutic preparations for topical application to the skin
GB1436614A (en) * 1972-07-17 1976-05-19 Thomae Gmbh Dr K Dermatological compositions
FR2450107A1 (en) * 1976-06-24 1980-09-26 Rorer Inc William H NEW COSMETIC AND PHARMACEUTICAL DETERGENT COMPOSITIONS BASED ON SARCOSINE
WO1999004757A1 (en) * 1997-07-24 1999-02-04 Societe D'exploitation De Produits Pour Les Industries Chimiques Seppic Use of a lipoaminoacid in a cosmetic formulation
WO2002013776A2 (en) * 2000-08-11 2002-02-21 The Procter & Gamble Company Method of providing improved deodorant application to the underarm
US20050037039A1 (en) * 2003-08-12 2005-02-17 Yarbrough William M. Composition for treatment of tinea pedis and method of use
WO2005018629A1 (en) * 2003-08-12 2005-03-03 Yarbrough William M Treatment for acne vulgaris and method of use

Also Published As

Publication number Publication date
FR2923383B1 (en) 2010-03-19
FR2923383A1 (en) 2009-05-15
WO2009060083A2 (en) 2009-05-14

Similar Documents

Publication Publication Date Title
WO2006013441A3 (en) Use of probiotic bacteria for the preparation of topical compositions for skin protection
WO2008085578A3 (en) Anti-microbial compositions and devices and methods of using the same
AU2015205914B2 (en) 1,6- diazabicyclo [3,2,1] octan- 7- one derivatives and their use in the treatment of bacterial infections
WO2010090860A3 (en) Methods and compositions for treating bacterial infection
WO2006136420A3 (en) Methods and means for protecting the skin against pathogenic microorganisms
WO2009074735A3 (en) Use of a novel natural agent in cosmetic compositions
WO2010003533A3 (en) Pyridopyrimidine compounds as anti-tubercular agents
WO2008041966A3 (en) Broad spectrum antibacterial compounds
WO2007130655A3 (en) Phage derived antimicrobial activities
EP2279662A3 (en) 5,7,4'-trihydroxy-3',5'-dimethoxyflavone as an antibacterial agent
ZA200903715B (en) Compositions, kits and uses for protecting the skin against pathogenic microorganisms
WO2010004433A3 (en) Hydrophobically enhanced aminoglycosides
WO2009031099A3 (en) Cosmetic use of microorganisms
WO2011140310A3 (en) Povidone-iodine topical composition
WO2008022186A3 (en) Antimicrobial sanitizing formulations with skin protection properties
WO2008010991A3 (en) Methods and compositions for the treatment of cancer
EP3330252A3 (en) Isoprenyl compounds and methods thereof
HK1133991A1 (en) Shampoo conditioner formulations comprising an avermectin for elimination of, and prophylaxis against, susceptible and treatment resistant strains of lice
WO2009085277A3 (en) Use of anti-connexin 43 polynucleotides for the treatment of abnormal or excessive scars
WO2011047320A3 (en) Antimicrobial compounds and methods of making and using the same
WO2008031940A3 (en) Xanthoxyline-based composition and cosmetic use thereof
WO2008046796A3 (en) Use of c10-c14-alkane-1,2-diols in the preparation of a composition for the prophylaxis and/or treatment of dermatophyte infections
WO2007124382A3 (en) Inhaled imipenem
EP3305305A3 (en) Silicate containing compositions and methods of treatment
WO2009101321A3 (en) Cationic surfactant compounds, use thereof as conditioner, cosmetic treatment method, and cosmetic or pharmaceutical compositions comprising same

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08847375

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 08847375

Country of ref document: EP

Kind code of ref document: A2